AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,894,497 | -15.1% | 1,858,556 | -12.7% | 0.01% | -15.4% |
| Q2 2023 | $152,987,470 | -9.1% | 2,128,966 | -22.0% | 0.01% | +62.5% |
| Q1 2023 | $168,380,678 | +197.2% | 2,729,908 | +271.7% | 0.01% | +33.3% |
| Q4 2022 | $56,647,126 | +263.9% | 734,437 | +110.5% | 0.01% | +200.0% |
| Q3 2022 | $15,568,000 | +72.2% | 348,896 | +47.8% | 0.00% | +100.0% |
| Q2 2022 | $9,039,000 | +77.5% | 235,991 | +91.8% | 0.00% | – |
| Q1 2022 | $5,092,000 | -68.6% | 123,020 | -71.3% | 0.00% | -100.0% |
| Q4 2021 | $16,207,000 | +16.1% | 428,983 | +1.3% | 0.00% | 0.0% |
| Q3 2021 | $13,954,000 | -41.0% | 423,342 | +20.8% | 0.00% | -50.0% |
| Q2 2021 | $23,647,000 | +23.9% | 350,535 | +4.0% | 0.00% | 0.0% |
| Q1 2021 | $19,082,000 | -8.7% | 337,011 | +31.4% | 0.00% | 0.0% |
| Q4 2020 | $20,891,000 | -38.9% | 256,428 | -46.6% | 0.00% | -33.3% |
| Q3 2020 | $34,207,000 | -27.8% | 480,103 | -16.6% | 0.00% | -40.0% |
| Q2 2020 | $47,348,000 | +122.6% | 575,454 | +59.2% | 0.01% | +66.7% |
| Q1 2020 | $21,271,000 | -42.9% | 361,568 | +0.3% | 0.00% | -25.0% |
| Q4 2019 | $37,256,000 | +1862700.0% | 360,440 | +360340.0% | 0.00% | – |
| Q3 2019 | $2,000 | -99.9% | 100 | -100.0% | 0.00% | – |
| Q3 2018 | $1,436,000 | -54.3% | 416,252 | -57.6% | 0.00% | – |
| Q2 2018 | $3,142,000 | +30.6% | 981,950 | 0.0% | 0.00% | – |
| Q1 2018 | $2,406,000 | -64.4% | 981,950 | -18.6% | 0.00% | -100.0% |
| Q4 2017 | $6,753,000 | -19.8% | 1,205,812 | -20.5% | 0.00% | 0.0% |
| Q3 2017 | $8,415,000 | -12.2% | 1,516,212 | -13.0% | 0.00% | 0.0% |
| Q2 2017 | $9,587,000 | +36.8% | 1,743,012 | -3.0% | 0.00% | 0.0% |
| Q1 2017 | $7,006,000 | -56.1% | 1,796,412 | -23.9% | 0.00% | -50.0% |
| Q4 2016 | $15,941,000 | -24.3% | 2,361,625 | -11.7% | 0.00% | -33.3% |
| Q3 2016 | $21,066,000 | +4.5% | 2,673,385 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $20,157,000 | -16.2% | 2,673,385 | -4.4% | 0.00% | 0.0% |
| Q1 2016 | $24,058,000 | -8.2% | 2,797,431 | -2.5% | 0.00% | -25.0% |
| Q4 2015 | $26,208,000 | – | 2,870,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |